Introduction to "nimesulide: beyond COX-2"

Clin Exp Rheumatol. 2001;19(1 Suppl 22):S1-2.

Author

T D Warner¹

Affiliation

¹ Department of Cardiac, Vascular and Inflammation Research, William Harvey Research Institute, St. Bartholomew's, Royal London School of Medicine and Dentistry, Charterhouse Square, London, EC1M 6BQ, U.K. t.d.warner@mds.qmw.ac.uk

PMID: 11296542

No abstract available

Publication types

Review

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Cyclooxygenase 1
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors / therapeutic use*
Humans
Isoenzymes / antagonists & inhibitors*
Membrane Proteins
Prostaglandin-Endoperoxide Synthases
Rheumatic Diseases / drug therapy*
Rheumatic Diseases / enzymology
Substrate Specificity
Sulfonamides / therapeutic use*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Isoenzymes
Membrane Proteins
Sulfonamides
Cyclooxygenase 1
Cyclooxygenase 2
PTGS1 protein, human
PTGS2 protein, human
Prostaglandin-Endoperoxide Synthases
nimesulide